Literature DB >> 26359701

Conjunctiva-Sparing Posterior Ptosis Surgery: A Novel Approach.

Ivan Vrcek1, Robert N Hogan, Jennifer Rossen, Ronald Mancini.   

Abstract

PURPOSE: Müller's muscle conjunctiva resection is a well-established means of correcting blepharoptosis. The primary objective of this prospective study was to determine if modifying Müller's muscle conjunctiva resection by sparing the conjunctiva would accomplish successful repair while allowing patients to retain their conjunctiva. The potential advantages of preserving conjunctiva are significant and include: conservation of an anatomically normal tissue, retention of goblet cells, reduction of suture-related complications such as corneal irritation or abrasion as the conjunctiva covers the suture during postoperative healing, and preservation of conjunctiva for potential future surgical procedures critical to ocular health.
METHODS: This is a prospective study enrolling patients with mild to moderate ptosis.
RESULTS: The procedure has been performed in 18 patients and 30 eyelids. Follow up at 1 week revealed normal healing with expected postoperative edema and ecchymosis. Notably, all patients were free of any corneal abrasion or irritation. Follow up at 1 month and a minimum of 3 months (average 5.7 months) revealed that all patients had satisfactory correction of their blepharoptosis with Margin Reflex Distance 1 (MRD1) improvement to within 1 mm of the anticipated goal, preserved eyelid margin contour, and good symmetry (average 0.26 mm difference in MRD1 between the sides).
CONCLUSION: These results show an effective correction of blepharoptosis with a favorable cosmetic outcome and low postoperative complication rate; all while preserving the conjunctiva.

Entities:  

Mesh:

Year:  2016        PMID: 26359701     DOI: 10.1097/IOP.0000000000000549

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  1 in total

1.  Evaluating the growth of eyelid lesions: comparison of clinical evaluation and a software-based model.

Authors:  Julie Linden Soto; Ivan Vrcek; Omar Ozgur; Ronald Mancini
Journal:  Int Ophthalmol       Date:  2016-11-10       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.